INTRODUCTION
In minimally invasive procedures, knowing exactly where a catheter is matters. Electromagnetic tracking systems make real-time navigation possible without line-of-sight constraints, but their accuracy depends entirely on the sensors embedded within those instruments. As device OEMs push toward smaller, more capable navigation platforms, the question of which sensors can reliably deliver sub-millimeter positional performance becomes a critical design decision.
This whitepaper from Quasar Medical presents an independent, bench-level performance evaluation of two Quasar-developed 5-DOF EM tracking sensors against commercially available reference sensors. Conducted by third-party testing organization Quadrant Scientific using an NDI Aurora Planar 20-20 V2 field generator, the study assesses positional accuracy, orientation accuracy, and stability under identical conditions — giving medical device engineers a data-driven framework for comparing sensor candidates before design lock.
YOU WILL LEARN
- Why positional RMS error, angular error, jitter, and drift are the right metrics to evaluate catheter-scale EM sensor performance
- How two Quasar sensors (Oz and Neptune) compared to commercially available reference sensors under identical calibration and test conditions
- What normalized sensitivity characterization reveals about manufacturing consistency across sensor populations
- How robotic gantry positioning eliminates operator variability and enables high-confidence spatial accuracy measurements
- Why all sensors being tested on the same calibration file (ROM) is essential for direct performance comparison
- What “comparable performance” actually means in numbers: RMS positional error, mean error, standard deviation, jitter, and drift values side by side
- How angular accuracy results differed between the two Quasar sensor models relative to their respective reference sensors
- What the study’s scope and limitations mean for OEMs evaluating these sensors for finished-device integration
- How Quasar Medical’s CDMO model supports sensor development from prototype through commercial production
STRATEGIC INSIGHT SECTION
Strategic Insight: Independent Validation Changes the Sensor Selection Conversation
Third-Party Testing Removes Ambiguity from Supplier Claims
The evaluation was conducted by Quadrant Scientific, an independent sensor testing and appraisal organization with no financial stake in the outcome. All sensors — Quasar-developed and commercially sourced reference sensors — were tested under identical excitation, calibration, and positioning conditions. This methodology removes the most common objection in supplier evaluations: that performance data was generated under favorable conditions. For OEMs, that means the numbers in this study are a direct comparative input, not marketing copy.
The Data Is Specific Enough to Matter
Quasar Oz demonstrated an RMS positional error of 1.18 mm versus 1.24 mm for Reference Sensor A — a difference of approximately 4.8%. Quasar Neptune came in at 1.11 mm RMS positional error against Reference Sensor B at 1.07 mm, a difference of roughly 3.7%. Angular error, jitter, and drift results followed the same pattern: differences within the same order of magnitude, with both Quasar sensors tracking within the sensitivity characterization ranges established during manufacturing population analysis. These are the kinds of figures that belong in a design input document.
Sensor Consistency Starts at Manufacturing
Both Quasar sensor populations (Oz and Neptune) demonstrated normalized electrical sensitivity values within a specified +/-5% window. Median sensitivity for Neptune was 1.0075; for Oz, 1.0040. That consistency matters not just for qualification but for predicting unit-to-unit variation in production — a parameter OEMs need to model when designing catheter-scale devices where sensor interchangeability is a regulatory and operational requirement.
What the Study Does Not Claim
The whitepaper is explicit: results apply only to the defined test conditions and are not intended to represent performance under dynamic motion, clinical, or in vivo use scenarios. No inter-operator variability study was conducted, and long-term aging or drift over extended use was not evaluated. This kind of scope transparency is itself a signal about how the data should be used — and how Quasar Medical positions itself as a development partner rather than just a component supplier.
GOVERNANCE / CHALLENGES
Integrating miniature EM sensors into catheter-scale devices requires navigating regulatory design controls under FDA 21 CFR Part 807 and EU MDR 2017/745 — the sensor component does not carry independent clearance. OEMs must validate performance within their specific finished-device context, meaning bench-level comparative data is a starting point, not an endpoint. Environmental variables including ferromagnetic distorters, alternate field generator models, and EM interference can alter tracking performance in ways that static laboratory evaluations cannot fully characterize. Sensor performance must also hold across manufacturing lot variation, making sensitivity population data as important as single-unit accuracy results.
IMPLEMENTATION / STRATEGY
For OEMs evaluating EM sensor suppliers, the path from bench data to design selection involves matching the test conditions in this study to your own system architecture — field generator model, measurement volume, and calibration approach all influence how results translate. Quasar Medical’s CDMO model is structured to support that process, from custom sensor development through sensor integration, prototype builds, and commercial production. The whitepaper’s underlying calibration records and methodology documentation are available on request, giving engineering teams the technical depth needed for their own design verification and validation activities.
WHO SHOULD READ THIS
This whitepaper is written for medical device engineers, systems architects, and R&D leaders at OEMs developing catheter-based navigation products, image-guided intervention platforms, or minimally invasive surgical systems that rely on EM tracking. It is equally relevant for regulatory affairs and quality teams evaluating supplier technical documentation as part of design control processes, and for procurement and strategic sourcing professionals comparing sensor component suppliers for new platform development.
FINAL CTA
Download Evaluating 5-DOF EM Tracking Sensor Performance for Minimally Invasive Navigation Systems from Quasar Medical to access the full comparative performance data, test methodology, and sensor characterization results needed to inform your EM sensor selection and design integration process.





